Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-022-00949-9, published online 15 July 2022
The authors are very sorry for two mistakes in the spelling of two authors’ names among the listed co-authors: The 9th author “Lu-ling Lin” and 11th author “Ming-jia Tan” were spelled incorrectly, and the correct spelling should be “Lu-lin Lin” and “Min-jia Tan”. These errors were made completely by accident, due to our negligence. The authors apologize for any inconvenience caused to the Journal and readers.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jiang, Kl., Liu, Cm., Nie, Lt. et al. Author Correction: Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition. Acta Pharmacol Sin 44, 2550 (2023). https://doi.org/10.1038/s41401-023-01132-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-023-01132-4
